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ABSTRACT
Background: Curcumin, a polyphenol derived from rhizome of Curcuma longa, has been successfully used in animals and 
humans due to its antibacterial and anti-inflammatory properties. Recently, a study demonstrated that curcumin ointment 
reduced pain, mammary tension and erythema in humans with mastitis 72 h after the treatment. Mastitis in sheep is an 
important problem due to restrictions associated to the use of antibiotics, affecting milk production and becoming a public 
health issue. Thus, the aim of this study was to verify whether the addition of curcumin in the diet of six female sheep with 
subclinical mastitis could have curative efficacy and benefits to animal health.
Cases: Six Lacaune sheep with subclinical mastitis that persisted for more than thirty days after the parturition were used. 
The animals received feed containing the curcumin (60 mg/animal/day) during 10 days. On days 0 and 10 of the experi-
ment, total blood was collected to perform the hemogram and serum biochemistry (triglycerides, cholesterol, glucose, total 
protein (TP), albumin, globulin, aspartate aminotransferase (AST) and urea), as well as individual milk samples for cen-
tesimal composition, somatic cell count (SCC) and total bacterial count (TBC). Total leukocytes and erythrocytes, as well 
as hemoglobin content, were obtained using the hematological counter CELM-CC-550. Blood smears were stained by the 
Romanowsky method and used for leukocytes differentiation. After ten days of treatment, five sheep were negative in the 
California Mastitis Test (CMT). Total erythrocytes increased, while total leukocytes decreased after the treatment. Seric 
levels of AST, triglycerides, cholesterol and globulins decreased, while seric levels of albumin and urea increased after ten 
days of treatment. No differences were observed regarding milk production and composition, as well as for SCC and TBC 
on days 0 and 10 post-treatment.
Discussion: The use curcumin to prevent or to delay the occurrence of subclinical mastitis in ewes was first tested. In an 
experiment of lipopolysaccharide-induced mastitis in rats, researchers identified receptors type Toll 4 which are related with 
the induction of the synthesis of pro-inflammatory cytokines, as tumor necrosis factor alpha, interleukin-6 and 1β, molecules 
involved in the migration of leukocytes to the site of inflammation. According to literature, curcumin was able to reduce the 
activity of myeloperoxidase in the mammary gland, an enzyme used as indicator of neutrophil infiltration, demonstrating 
the potent anti-inflammatory effect of curcumin. This effect can be associated to the release of interleukin-8, a cytokine that 
promotes the migration of neutrophils, lymphocytes and eosinophils into the site of infection, i.e., the mammary gland. It is 
important to highlight that neutrophils, due to its capacity to release inflammatory mediators and to delay apoptosis, has the 
potential to maintain a permanent inflammatory process, effects that were prevented or reduced by curcumin, specially the 
apoptotic and cytotoxic effects. It is important to emphasize the direct effect of curcumin on bacteria present in the mam-
mary gland, since it exerts potent bactericidal effect. In summary, the use of curcumin in sheep with subclinical mastitis 
exerted beneficial effects in the dose of 60 mg/sheep/day, since it showed 83.3% of curative efficacy in the test CMT. This 
effect of curcumin can be direct or indirect, since the curcumin provided in the diet showed anti-inflammatory properties by 
reducing oxidation reactions and cell damage. Overall, the addition of curcumin in sheep diet improved the hematological 
and biochemical variables after only ten days of treatment. Future studies should be performed to clarify and determine 
whether the curcumin provided in diet can be an alternative to treat clinical or subclinical mastitis.
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INTRODUCTION
The production of sheep milk and milk prod-
ucts represent a significant source of income in the 
sheep industry. However, subclinical mastitis is the 
main issue associated with decreased milk quantity 
and quality [15], loss of cheese yield and rennet firm-
ness, resulting in economic losses to farmers and dairy 
industries [18]. The prevalence of subclinical mastitis 
in sheep varies from 9.23 to 28.1% [8,15], being the 
coagulase-negative the most incident agent [15]. Ac-
cording to literature [21], tetracycline and aminoglyco-
sides are the most commonly used antibiotics to combat 
mammary infections in sheep. However, the use of 
antibiotics in animals is restricted in several countries 
due to concerns regarding microbial resistance in ani-
mals and humans [9,19], leaving the discard of affected 
animals as the only alternative. As a consequence, the 
use of natural compounds in the diet of these animals 
has gained importance due to their beneficial effects 
associated to the improvement of animal health and 
disease resistance, as the use of curcumin [7].
Curcumin, a polyphenol derived from rhi-
zome of Curcuma longa, has been successfully used 
in animals and humans due to its antibacterial and 
anti-inflammatory properties [14,27,33]. Recently, a 
study demonstrated that curcumin ointment reduced 
pain, mammary tension and erythema in humans with 
mastitis 72 h after the treatment [1]. Also, in experi-
mental procedures, the use of curcumin reduced the 
inflammatory process in lipopolysaccharide-induced 
mastitis in mice [14]. Therefore, the aim of this study 
was to evaluate the addition of curcumin in the diet of 
6 female sheep with subclinical mastitis regarding its 
curative effect and benefits to animal health.
CASE
Six Lacaune sheep (multiparous with 2 to 4 
gestations) diagnosed with subclinical mastitis of a 
dairy farm located in Southern Brazil were used in this 
study. Subclinical mastitis was diagnosed using the 
California Mastitis Test (CMT) in the first days after 
parturition before milking, and the animals remained 
positives than 30 days. The animals were not treated 
with antibiotics, since in this farm positive animals are 
discarded to avoid milk drug residue. After the diag-
nosis, the animals were transferred to isolated stalls (4 
m x 10 m) with straw bedding, water ad libitum and 
individual feeding based on corn silage twice a day. In 
the beginning of the experiment, the animals were fed 
with a concentrate (300 g/sheep) containing curcumin 
(200 mg/kg of ration = 60 mg curcumin/day/animal) 
once a day during 10 consecutive days in individual 
feeders. The concentrate was based on corn and wheat 
bran in order to obtain 16 % of crude protein, while 
the curcumin1 (98% of purity) was purchased from 
China. Physical examination with special attention to 
the mammary glands was performed in the beginning 
of the experiment (day 0) and on day day 10. None of 
the animals showed hyperthermia, swelling or defor-
mities in the mammary gland, which characterize the 
occurrence of subclinical mastitis when associated to 
positive CMT test. On days 0 and 10, the CMT was 
performed based on the protocol stablished [28], being 
considered positive when the CMT score was above 1.
The quantity of milk produced per sheep was 
evaluated on days 0 and 10 of the experiment using 
the Milk Meter2 coupled to a mechanical milking pipe. 
Teats were cleaned and disinfected with alcohol (70%), 
and the first three milk jets were discarded, followed 
by manual collection of milk (50 mL) in sterile and 
individual bottles for bacterial total count (TBC). For 
the centesimal analysis and somatic cell count (SCC), 
40 mL of milk was collected and stored in tubes con-
taining bronopol. Blood sampling was performed on 
days 0 and 10 of the experiment right before feeding 
by jugular venipuncture in tubes containing EDTA as 
anticoagulant (4 mL) and in tubes without anticoagu-
lant (4 mL). The total blood collected in tubes without 
anticoagulant was centrifuged at 5600 g during 10 min, 
and serum was stored in microtubes at - 20ºC.
The content of fat, protein, lactose, defatted 
dry extract (DDE), total dry extract (TDE) and SCC 
was performed by an accredited laboratory using the 
infrared method according the methodologies defined 
by the International Dairy Federation (IDF), while the 
SCC was performed using flow cytometry. For TBC 
analyses, 1 mL of each milk sample was serially di-
luted using buffered peptone water (1%) and 1 mL of 
each dilution was pour plated using Plate Count Agar 
(PCA), followed by incubation at 37ºC for 48 h. The 
result was expressed as the number of bacterial colony 
forming unit (CFU).
Total leukocytes and erythrocytes, as well 
as hemoglobin content, were obtained using the he-
matological counter3. Blood smears were stained by 
the Romanowsky method and used for leukocytes 
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differentiation. The globular volume (GV), as well 
as the mean corpuscular volume (MCV) and mean 
corpuscular hemoglobin (MCH), were calculated 
based on the count of erythrocytes and hemoglobin 
content, as follows: (MCV = GV x 10/ erythrocytes); 
(MCH = hemoglobin x 100/GV). The seric levels of 
triglycerides, cholesterol, glucose, total protein (TP), 
albumin, aspartate aminotransferase (AST) and urea 
were measured in a semi-automatic analyzer4 using 
specific kits5 and following the manufacturer’s rec-
ommendations. Globulin values were obtained by the 
difference between TP and albumin.
Milk production, composition and quality, as 
well as hematological and biochemical data were sub-
mitted to normality test, and when were not normally 
distributed, were transformed to logarithm. The Stu-
dent t-test was used to compare the difference between 
days 0 and 10, considering P < 0.05. The results were 
shown as mean and standard deviation.
Milk volume of treated animals increased ap-
proximately 0.1-0.4 L/sheep/day (Figure 1), as well 
as observed for fat, protein, lactose, DDE, TDE, SCC 
and TBC (Table 1). After ten days of treatment, five 
sheep were negative in the CMT test, thus, only 1 sheep 
remained positive for subclinical mastitis.
In the beginning of study (day 0), total leu-
kocytes was higher compared to reference values, 
but reduced after curcumin ingestion, which can be 
directly linked with a reduction on the total count of 
segmented neutrophils, lymphocytes and eosinophils. 
On the day 0, total erythrocytes was lower compared 
to reference value, but increased on day 10. The MCH 
index increased, while the MCV index reduced after the 
addition of curcumin in the diet (Table 2). Seric levels 
of AST, globulins, albumin, cholesterol, triglycerides 
and urea changed in curcumin treated animals (Table 
2). Seric AST activity, as well as globulin and triglycer-
ides levels decreased, while seric levels of albumin and 
urea increased on day 10 compared to day 0 (Table 2).
DISCUSSION
In an experiment of lipopolysaccharide-
induced mastitis in rats, researchers identified re-
ceptors type Toll 4 (TLR4), which are related with 
the induction of the synthesis of pro-inflammatory 
cytokines, as tumor necrosis factor alpha (TNF-α), 
interleukin-6 (IL-6) and IL-1β, molecules involved in 
the migration of leukocytes to the site of inflammation 
[20]. The curcumin was able to reduce the activity of 
myeloperoxidase (MPO) in the mammary gland [35], 
an enzyme used as indicator of neutrophil infiltration, 
demonstrating the potent anti-inflammatory effect of 
Figure 1. Individual milk production of 6 ewes with subclinical 
mastitis supplemented with curcumin during 10 consecutive days. 
No significant difference was observed between day 0 and 10); 
however, numerically it is possible to verify that milk production 
increased with the addition of concentrate and curcumin in the 
diet. Only one sheep was positive in the California Mastitis Test 
after 10 days of treatment.
Variable Day 0 Day 10 P
Production (L/day) 0.88 ± 0.33 1.08 ± 0.47 >0.05
Fat (g/100 g) 7.32 ± 1.69 7.81 ± 1.19 >0.05
Protein (g/100 g) 4.70 ± 0.40 4.88 ± 0.33 >0.05
Lactose (g/100 g) 4.35 ± 0.24 4.38 ± 0.17 >0.05
TDE (g/100 g) 17.36 ± 1.77 17.95 ± 1.11 >0.05
DDE (g/100 g) 10.04 ± 0.32 10.11 ± 0.34 >0.05
SCC (x1000/mL) 1094.1 ± 779.4 836.0 ± 601.3 >0.05
TBC (UFC/mL) 449.1 ± 685.1 396.1 ± 664.3 >0.05
Table 1. Sheep milk production, composition and bacterial count after 0 and 10 days of curcumin dietary supplementation (60 mg/animal/day).
Results are shown as mean and standard deviation. TDE (total dry extract); DDE (defatted dry extract); SCC (somatic cell count) and TBC (total bacterial count).
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curcumin [14]. This effect can be associated to the 
release of IL-8, a cytokine that promotes the migration 
of neutrophils, lymphocytes and eosinophils into the 
site of infection, i.e., the mammary gland [12,32]. Also, 
other studies have demonstrated that curcumin is able 
to block the activation of enzymes linked to the release 
and proliferation of neutrophils, as cyclooxygenase and 
phospholipases [16,29]. It is important to highlight that 
neutrophils, due to its capacity to release inflammatory 
mediators and to delay apoptosis, has the potential to 
maintain a permanent inflammatory process [10,34], 
effects that were prevented or reduced by curcumin, 
especially the apoptotic and cytotoxic effects [3]. 
These mechanisms can explain the decrease on total 
leukocyte counts, as well as the numeric decrease on 
SCC in most animals (n = 4). Moreover, it is important 
to emphasize the direct effect of curcumin on bacteria 
present in the mammary gland, since it exerts potent 
bactericidal effect [7,33], contributing to the reduc-
tion of the inflammatory process, as occurred in this 
present study.
Due to the improvement of sheep health, all 
animals showed a numerical increase on milk volume 
(Figure 1). This result is important and reinforces the 
possibility to use curcumin to prevent or to delay the 
occurrence of subclinical mastitis, since affected ani-
mals showed a reduction on performance and conse-
quently important economic losses to milk farms [15]. 
However, according to researchers [1], increased of 
milk TBC may not coincide with the clinical manifesta-
tion of subclinical mastitis. In this sense, the use of cur-
cumin associated to other natural products may cause 
a reduction on TBC in milk of cows with subclinical 
mastitis [9], and in higher doses curcumin improved 
immunological response and showed anticoccidian 
effect in lambs [11,26]. In summary, higher doses or 
a more prolonged period of treatment with curcumin 
may reduce TBC and SCC.
Variable Reference values Day 0 Day 10 P
GV (%)1 27 - 45 30.6 ± 4.1 31.6 ± 3.8 >0.05
Erythrocytes (x106 / µL)1 9.0 - 15.0 8.6 ± 1.7 11.5 ± 0.9 <0.05
Hemoglobin (g/dL)1 9.0 - 15.0 9.23 ± 1.21 10.4 ± 1.8 >0.05
MCV (fl)1 28 - 40 33.07 ± 4.7 27.4 ± 1.7 <0.05
MCH (%)1 31 - 34 29.9 ± 0.89 32.8 ± 2.14 <0.05
Total leukocytes (µL)1 4000 - 12000 39116 ± 24499 10341 ± 3791 <0.05
Rods (µL)1 Rare 0.0 ± 0.0 67.5 ± 80.7 >0.05
Segmented neutrophils (µL)1 700 - 6000 19147 ± 12687 4734 ± 1654 <0.05
Lymphocytes (µL)1 2000 - 9000 14101 ± 7108 4167 ± 1850 <0.05
Monocytes (µL)1 0 - 750 2818 ± 2597 947  ± 320 >0.05
Eosinophils (µL)1 0 - 1000 3100 ± 2416 425 ± 478 <0.05
Basophiles (µL)1 0 - 300 0.0 ± 0.0 0.0 ± 0.0 >0.05
AST (UI/L)2 0 - 90 47.4 ± 7.8 36.8  ± 2.7 <0.05
Total protein (g/dL)2 6.0 - 7.9 7.66 ± 0.36 7.26 ± 0.64 >0.05
Albumin (g/dL)2 2.4 - 3.0 1.93 ± 0.41 2.4 ± 0.4 <0.05
Globulins (g/dL)2 3.5 - 5.7 5.73 ± 0.56 4.86 ± 0.67 <0.05
Cholesterol (mg/dL)2 52 - 76 70.6 ± 19.3 68.6 ± 19.1 >0.05
Triglycerides (mg/dL) w/d 25.1 ± 6.4 17.6 ± 3.6 <0.05
Glucose (mg/dL)2 50 - 80 82.3 ± 15.3 70.8 ± 10.8 >0.05
Urea (mg/dL)2 17.12 - 42.8 22.0 ± 5.38 29.3 ± 6.4 <0.05
Table 2. Hemogram and serum biochemistry of sheep with mastitis after 0 and 10 days of curcumin dietary supplementation (60 mg/animal/day).
Results are shown as mean and standard deviation. GV (globular volume); MCV (mean corpuscular volume); MCH (mean corpuscular hemoglobin), 
and AST (Aspartate aminotransferase). 1Feldman et al. [13]; 2Kaneko et al. [17]. w/d = without data in the literature.
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The use of curcumin caused a reduction on 
seric levels of triglycerides and cholesterol, in agree-
ment with literature [5,26]. Recently, the use of cur-
cumin was associated with positive effects due to its 
hypocholesterolemic effects by a reduction on total 
cholesterol and low-density lipoprotein (LDL) levels, 
and increase on high-density lipoprotein (HDL) levels, 
being these results related to the inhibition of enzyme 
3-hidroxi-3-methyl-glutaril-CoA reductase (HMG-
CoA reductase) activity [31]. The use of curcumin in 
rats with renal damage exerted effect on the reduction 
of urea and creatinine levels [6], in disagreement to 
what was observed in this present study. This data may 
not be linked with curcumin, but with the addition of 
300 g of concentrate in the diet (food not present in 
the diet before the beginning of experiment), which 
caused an increase in the synthesis and degradation of 
proteins, and consequently, increased on albumin and 
urea levels by metabolic pathways, respectively. More-
over, it is important to emphasize that curcumin avoids 
the augmentation of AST and alanine aminotransferase 
(ALT) seric levels in rats intoxicated with lead, demon-
strating its hepaprotective properties. In our study, the 
seric ASAT levels decreased, and remained within the 
reference values in both sampling times [13].
The consumption of a diet supplemented with 
curcumin was able to decrease seric globulin levels, 
as well as observed for total leukocyte count. A study 
verified that curcumin reduced seric levels of C-reac-
tive protein (CRP) [31], an important inflammatory 
biomarker produced during acute inflammation [23], 
infection and tissue damage [25], which may explain 
the reduction on seric globulin levels in sheep with 
subclinical mastitis that received curcumin. More-
over, in vitro studies proved the inhibitory effects of 
curcumin on the proliferation of T helper lymphocytes 
and immunoglobulin IgG [30], which also explain the 
reduction on seric globulin levels.
The increase on erythrocyte count and MCH 
index, and the decrease on MCV index, can be linked 
with indirect effects of curcumin and/or due to the 
improvement of immune response and inflammatory 
process. It is important to emphasize that antioxidant 
enzymes, as catalase (CAT), glutathione peroxidase 
(GPx) and glutathione S-transferase (GST) were 
increased in erythrocytes of in animals treated with 
curcumin [22]. These antioxidants enhance cellular 
protection and avoid oxidative damage in cell mem-
branes [22,24], which can contribute to augmentation 
on erythrocyte counts observed in this present study. 
 The use of curcumin in sheep with subclini-
cal mastitis exerted beneficial effects in the dose of 
60 mg/sheep/day, since it showed 83.3% of curative 
efficacy. This effect of curcumin can be direct or indi-
rect, since the curcumin provided in the diet showed 
anti-inflammatory properties by reducing oxidation 
reactions and cell damage [2,4]. Overall, the addition 
of curcumin in sheep diet improved the hematological 
and biochemical variables after only ten days of treat-
ment. Future studies should be performed to clarify and 
determine whether the curcumin provided in diet can 
be an alternative to treat clinical or subclinical mastitis.
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